Press Room | News
EN | NL
Feb 2, 2012
Amakem to Present at Glaucoma 360: New Horizons Forum
Nov 2, 2011
Amakem Announces Further Proof-of-Concept Results for its ‘Localized Drug Action’ Platform
Sep 6, 2011
Amakem raises €18m in a Series A round to advance its ophthalmology drug development programs
Nov 15, 2010
Amakem receives 1.28M€ government funding for COPD drug development program
Sep 15, 2010
Amakem’s ROCK inhibitor program delivers proof of concept for the “Localized Drug Action” platform
Feb 11, 2010
Amakem, a new Flemish drug discovery company starts operations for treatments of major chronic diseases